Share Plans (Details) (USD $)	0 Months Ended	3 Months Ended		9 Months Ended
	Jun. 28, 2013	Jun. 28, 2013	Jun. 29, 2012	Jun. 28, 2013	Jun. 29, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation cost		$ 4,600,000	$ 2,600,000	$ 11,400,000	$ 8,300,000
Conversion of Covidien Equity Awards
Shares Options, Outstanding	2,399,822	2,399,822		2,399,822
Shares Options, Exercisable	550,097	550,097		550,097
Weighted- Average Exercise Price, Outstanding options	$ 35.94	$ 35.94		$ 35.94
Weighted- Average Exercise Price, Exercisable options	$ 30.94	$ 30.94		$ 30.94
Weighted- Average Remaining Contractual Term, Outstanding options	3 years 9 months 18 days
Weighted- Average Remaining Contractual Term, Exercisable options	2 years 4 months 24 days
Aggregate Intrinsic Value, Outstanding options	22.9	22.9		22.9
Aggregate Intrinsic Value, Exercisable options	$ 8.0	$ 8.0		$ 8.0
Pre-Separation
Conversion of Covidien Equity Awards
Shares Options, Outstanding	1,745,258	1,745,258		1,745,258
Weighted Average Assumptions
Expected share price volatility	26.00%
Risk-free interest rate	0.99%
Expected annual dividend per share	1.65%
Expected life of options (in years)	3 years 9 months 18 days
Fair value per option	$ 18.04	$ 18.04		$ 18.04
Post-Separation
Conversion of Covidien Equity Awards
Weighted-Average Grant-Date Fair Value, Share options	$ 7.96	$ 7.96		$ 7.96
Shares Options, Outstanding	2,399,822	2,399,822		2,399,822
Weighted Average Assumptions
Expected share price volatility	32.00%
Risk-free interest rate	0.99%
Expected annual dividend per share	0.00%
Expected life of options (in years)	3 years 9 months 18 days
Fair value per option	$ 16.51	$ 16.51		$ 16.51
Restricted Share Units | Post-Separation
Conversion of Covidien Equity Awards
Awards, Restricted share units	552,305	552,305		552,305
Weighted Average Grant Date Fair Value, Restricted share units	$ 36.09	$ 36.09		$ 36.09